HNVR · Hanover Bancorp, Inc. /MD
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-15 | Golden Robert |
Director |
Sell↓
Filing footnotes — Common Stock (Indirect)
These shares were sold from a trust for the benefit of the Reporting Person. 182,515 shares held in trusts for the benefit of the Reporting Person, and of which the spouse of the Reporting Person is a trustee. |
Common Stock
(I)
|
661 |
| 2026-06-12 | Golden Robert |
Director |
Sell↓
Filing footnotes — Common Stock (Indirect)
These shares were sold from a trust for the benefit of the Reporting Person. |
Common Stock
(I)
|
3,763 |
| 2026-06-10 | Golden Robert |
Director |
Sell↓
Filing footnotes — Common Stock (Indirect)
These shares were sold from a trust for the benefit of the Reporting Person. 186,939 shares held in trusts for the benefit of the Reporting Person, and of which the spouse of the Reporting Person is a trustee. |
Common Stock
(I)
|
8,419 |
| 2026-06-02 | Golden Robert |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold from the Reporting Person's direct holdings. |
Common Stock
|
1,847 |
| 2026-05-29 | Golden Robert |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold from the Reporting Person's direct holdings. |
Common Stock
|
1,514 |
| 2026-05-27 | Golden Robert |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
These shares were sold from the Reporting Person's direct holdings. |
Common Stock
|
1,295 |
| 2026-05-20 | Golden Robert |
Director |
Sell↓
|
Common Stock
|
1,012 |
| 2026-05-19 | Golden Robert |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in two separate transactions at prices of $22.7498 and $22.825, inclusive. The reporting person undertakes to provide to Hanover Bancorp, Inc., any security holder of Hanover Bancorp, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price mentioned within this footnote. |
Common Stock
|
2,259 |
| 2026-05-06 | Golden Robert |
Director |
Convert↓
Filing footnotes — Stock Options (Direct)
Stock Options granted pursuant to the 2016 Stock Option Plan are fully vested and exercisable. |
Stock Options
|
10,000 |
| 2026-05-06 | Golden Robert |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
10,000 shares of common stock were acquired from the exercise of stock options on May 6, 2026. |
Common Stock
|
10,000 |
| 2026-05-01 | Diiorio Lisa A |
FSVP & Chief Accounting Off. |
Tax↓
|
Common Stock
|
3,879 |
| 2026-05-01 | Diiorio Lisa A |
FSVP & Chief Accounting Off. |
Convert↓
Filing footnotes — Stock Options (Direct)
Stock Options granted pursuant to the 2013 Stock Option Plan are fully vested and exercisable. |
Stock Options
|
6,000 |
| 2026-05-01 | Diiorio Lisa A |
FSVP & Chief Accounting Off. |
Convert↑
|
Common Stock
|
6,000 |
| 2026-02-20 | Corbett Kevin |
EVP & Chief Credit Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 27, 2022. |
Common Stock
|
600 |
| 2026-02-20 | Corbett Kevin |
EVP & Chief Credit Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 29, 2025. |
Common Stock
|
157 |
| 2026-02-20 | PUORRO MICHAEL P |
Director, Chairman & CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 27, 2022. |
Common Stock
|
2,216 |
| 2026-02-20 | Wilcox McClelland W |
President |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 24, 2023. |
Common Stock
|
536 |
| 2026-02-20 | Diiorio Lisa A |
FSVP & Chief Accounting Off. |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 19, 2024. |
Common Stock
|
83 |
| 2026-02-20 | Burke Lance P |
SEVP & Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 27, 2022. |
Common Stock
|
572 |
| 2026-02-20 | Corbett Kevin |
EVP & Chief Credit Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 24, 2023. |
Common Stock
|
198 |
| 2026-02-20 | Diiorio Lisa A |
FSVP & Chief Accounting Off. |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 29, 2025. |
Common Stock
|
76 |
| 2026-02-20 | PUORRO MICHAEL P |
Director, Chairman & CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 29, 2025. |
Common Stock
|
673 |
| 2026-02-20 | Wilcox McClelland W |
President |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 19, 2024. |
Common Stock
|
624 |
| 2026-02-20 | Burke Lance P |
SEVP & Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 19, 2024. |
Common Stock
|
232 |
| 2026-02-20 | Diiorio Lisa A |
FSVP & Chief Accounting Off. |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 27, 2022. |
Common Stock
|
428 |
| 2026-02-20 | Wilcox McClelland W |
President |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 27, 2022. |
Common Stock
|
1,820 |
| 2026-02-20 | PUORRO MICHAEL P |
Director, Chairman & CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 19, 2024. |
Common Stock
|
814 |
| 2026-02-20 | Burke Lance P |
SEVP & Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 24, 2023. |
Common Stock
|
187 |
| 2026-02-20 | PUORRO MICHAEL P |
Director, Chairman & CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 24, 2023. |
Common Stock
|
680 |
| 2026-02-20 | Vivona John P |
EVP & Chief Risk Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 29, 2025. |
Common Stock
|
95 |
| 2026-02-20 | Burns Joseph F |
EVP & Chief Lending Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 29, 2025. |
Common Stock
|
188 |
| 2026-02-20 | Burke Lance P |
SEVP & Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 29, 2025. |
Common Stock
|
220 |
| 2026-02-20 | Corbett Kevin |
EVP & Chief Credit Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 19, 2024. |
Common Stock
|
232 |
| 2026-02-20 | Wilcox McClelland W |
President |
Tax↓
Filing footnotes — Common Stock (Direct)
Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 29, 2025. |
Common Stock
|
421 |
| 2026-02-06 | Golden Robert |
Director |
Sell↓
Filing footnotes — Common Stock (Indirect)
195,358 shares held in trusts for the benefit of the Reporting Person, and of which the spouse of the Reporting Person is a trustee. |
Common Stock
(I)
|
700 |
| 2026-02-05 | Diiorio Lisa A |
FSVP & Chief Accounting Off. |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. |
Common Stock
|
1,062 |
| 2026-02-05 | Haspel Ahron H |
Insider |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. |
Common Stock
|
1,592 |
| 2026-02-05 | Golden Robert |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. |
Common Stock
|
1,592 |
| 2026-02-05 | Sisti Elena |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. |
Common Stock
|
1,592 |
| 2026-02-05 | PUORRO MICHAEL P |
Director, Chairman & CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. |
Common Stock
|
10,945 |
| 2026-02-05 | Golden Robert |
Director |
Sell↓
|
Common Stock
(I)
|
500 |
| 2026-02-05 | Burke Lance P |
SEVP & Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. |
Common Stock
|
3,185 |
| 2026-02-05 | Katz Michael David M.D. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. |
Common Stock
|
1,592 |
| 2026-02-05 | Abraham Varkey |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. |
Common Stock
|
1,592 |
| 2026-02-05 | Sorrenti John R |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. |
Common Stock
|
1,592 |
| 2026-02-05 | Vivona John P |
EVP & Chief Risk Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. |
Common Stock
|
1,338 |
| 2026-02-05 | Corbett Kevin |
EVP & Chief Credit Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. |
Common Stock
|
2,198 |
| 2026-02-05 | Negrin Metin |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. |
Common Stock
|
1,592 |
| 2026-02-05 | Burns Joseph F |
EVP & Chief Lending Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. |
Common Stock
|
2,592 |
| 2026-02-05 | Okun Philip A |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. |
Common Stock
|
1,592 |